Your Paper Your Way
We now differentiate between the requirements for new and revised submissions. You may choose to submit your manuscript as a single Word or PDF file to be used in the refereeing process. Only when your paper is at the revision stage, will you be requested to put your paper in to a 'correct format' for acceptance and provide the items required for the publication of your article.
To find out more, please visit the Preparation section below.
The editorial board of the Journal of Medical Imaging and Radiation Sciences (JMIRS) welcomes the submission of manuscripts devoted to all fields of diagnostic imaging and radiation therapies, including nuclear medicine, radiation therapy, magnetic resonance, radiological technology, mammography, interventional radiography, dosimetry, computed tomography, pharmacology and medical ethics.
The JMIRS disseminates recent research, new technology and techniques, professional practices and other relevant knowledge that helps medical radiation technologists advance quality and innovation in patient care.Each article submitted for publication in JMIRS is forwarded for review to two peer reviewers. The review process is double blind, meaning that both the author and the reviewer will remain anonymous throughout the process. The purpose of the review process is to benefit from the reviewers' knowledge and experience, to gain the reviewers' critical assessment of the article, and to provide concrete feedback to the contributor(s). The review process helps the editorial board in making decisions about articles for publication, and also guides contributors in strengthening their professional writing. TYPES OF ARTICLE
- Original full length research papers (Qualitative, Quantitative, Randomized trial or observational research)
- Review articles (Literature reviews, Systematic reviews)
- Case studies and/or clinical cases
- Letter to the Editor
If you are submitting a paper reporting randomized trials, you will be asked to upload the completed a 25-item CONSORT checklist along with your manuscript submission. CONSORT (Consolidated Standards of Reporting Trials) is an evidence-based, minimum set of recommendations for reporting randomized trials. It offers a standard way for authors to prepare reports of trial findings, facilitating their complete and transparent reporting, and aiding their critical appraisal and interpretation. The checklist items focus on reporting how the trial was designed, analyzed, and interpreted.If you are submitting a paper reporting observational research, you will be asked to upload the completed STROBE checklist (PDF or Word) for cohort, case-control, and/or cross-sectional studies.
Review Articles: Review articles must include an abstract (150 words) and the articles should be approximately 3,000 words in length. Review articles use the existing knowledge base to draw conclusions on a subject area of interest. Review articles discuss and debate the issues. A systematic review is a review of a clearly formulated question that uses systematic and explicit methods to identify, select, and critically appraise relevant research, and to collect and analyze data from the studies that are included in the review. Statistical methods (meta-analysis) may or may not be used to analyze and summarize the results of the included studies. Meta-analysis refers to the use of statistical techniques in a systematic review to integrate the results of included studies. If you are submitting reports of meta-analyses of randomized controlled trials, you will be asked to upload the completed 27-item PRISMA checklist (PDF or Word) document, which includes the title, abstract, methods, results, discussion and funding. The aim of the PRISMA Statement is to help authors report a wide array of systematic reviews to assess the benefits and harms of a health care intervention. PRISMA focuses on ways in which authors can ensure the transparent and complete reporting of systematic reviews and meta-analyses.
Editorials/Commentaries (Submitted or Invited):Classic editorial - addresses contemporary topics of interest and provides thought-provoking discussion. The presentation of new hypotheses and novel ideas is welcome.
Debate - brief provocative accounts that provide differing perspective or perspectives on a single shared issue or topic of discussion. Their focus may be similar to that of editorials and viewpoints but these are generally shorter pieces that make one or two salient points.Viewpoint - similar to editorials but allow the inclusion of personal perspectives and opinion. Viewpoints may choose to address contentious issues in medical radiation sciences and may therefore contain controversial views.
These can be anywhere between 1,000 and 4,000 words, and should not exceed 25 references. Note that these will not be peer reviewed; however, they will be reviewed by the Editor-in-Chief and Deputy Editor for appropriateness and suitability with our audience. Editorials can be submitted directly to the Managing Editor at firstname.lastname@example.org.Letters to the Editor: This is correspondence typically pertaining to a recent or concurrently published article within JMIRS. Usually comments and critiques will be passed on to the authors of the original article; however, this will not determine the outcome of review and publication. General correspondence to the Editor regarding any aspect of medical radiation sciences or the JMIRS is also encouraged. Submit letters in a Word document directly to the Managing Editor at: email@example.com. 500 words or less are preferred, and letters addressing a specific article must reach us within 2 months of publication of the original item. Please see Submit Letter to the Editor for more information. Ethics in publishing
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
- conception and design of the study, or acquisition of data, or analysis and interpretation of data;
- drafting the article or revising it critically for important intellectual content;
- final approval of the version to be submitted.
Plagiarism:This includes several forms:
- General plagiarism - the use of others' published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than derived from an existing source. Plagiarism is scientific misconduct (see Permissions).
- Self-plagiarism - this refers to the practice of an author using portions of their previous writings on the same topic in another of their publications, without specifically citing it formally in quotes. This practice is widespread and sometimes unintentional, as there are only so many ways to say the same thing on many occasions, particularly when writing the Methods section of an article. However, it is considered scientific misconduct if not properly attributed, or if large sections are simply copied and pasted.
- Divided publication/redundant publication - sometimes called "salami" publication, where papers cover the same population, methods, and question. A distinction needs to be made between salami and redundant publication: where there is a two thirds overlap, it is redundant publication. If the hypotheses were completely separate questions, then it is acceptable for them to be posed in two separate papers. If they are related questions, or very closely related, then they should be published as a single paper. Splitting up papers by outcomes ("salami slicing") is not legitimate.
Studies on patients or volunteers require ethics committee approval and informed consent which should be documented in your paper. Patients have a right to privacy. Therefore identifying information, including patients images, names, initials, or hospital numbers, should not be included in videos, recordings, written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and you have obtained written informed consent for publication in print and electronic form from the patient (or parent, guardian or next of kin where applicable). If such consent is made subject to any conditions, Elsevier must be made aware of all such conditions. Written consents must be provided to Elsevier on request. Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. If such consent has not been obtained, personal details of patients included in any part of the paper and in any supplementary materials (including all illustrations and videos) must be removed before submission.
CONFLICT OF INTEREST
Conflict of Interest for Authors: The potential for conflict of interest exists when an author, the author's institution, reviewer or editor has financial relationships (such as employment, consultancy, stock ownership, honoraria and paid expert testimony) that may inappropriately influence his or her actions. Other forms of conflict of interest include personal, academic and intellectual issues. Any potential conflict of interest should be disclosed in the cover letter. Sources of outside support for research, including funding, equipment, and drugs, must be named in the cover letter. If an author has no conflicts of interest to declare, this must be explicitly stated. Authors should contact the Editorial Office with questions or concerns, but should err on the side of inclusion when in doubt. Manuscripts that fail to include the complete statements of all authors upon submission will be returned to the corresponding author and will delay the processing and evaluation of the manuscript.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see 'Multiple, redundant or concurrent publication' section of our ethics policy for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service CrossCheck.
This journal offers you the option of making your article freely available to all via the ScienceDirect platform. To prevent any conflict of interest, you can only make this choice after receiving notification that your article has been accepted for publication. The fee of $1,700 excludes taxes and other potential author fees such as colour charges. In some cases, institutions and funding bodies have entered into agreement with Elsevier to meet these fees on behalf of their authors. Details of these agreements are available at http://www.elsevier.com/fundingbodies. Authors of accepted articles, who wish to take advantage of this option, should complete and submit the order form (available at http://www.elsevier.com/locate/openaccessform.pdf). Whatever access option you choose, you retain many rights as an author, including the right to post a revised personal version of your article on your own website. More information can be found here: http://www.elsevier.com/authorsrights. Authors can specify that they would like to select this option after receiving notification that their article has been accepted for publication, but not before. This eliminates a potential conflict of interest by ensuring that the journal does not have a financial incentive to accept an article for publication.
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
For open access articles: Upon acceptance of an article, authors will be asked to complete an 'Exclusive License Agreement' (more information). Permitted third party reuse of open access articles is determined by the author's choice of user license.Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. More information.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Funding body agreements and policies
Elsevier has established a number of agreements with funding bodies which allow authors to comply with their funder's open access policies. Some funding bodies will reimburse the author for the Open Access Publication Fee. Details of existing agreements are available online.
For non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.
The open access publication fee for this journal is USD 3300, excluding taxes. Learn more about Elsevier's pricing policy: https://www.elsevier.com/openaccesspricing.
Green open access
Authors can share their research in a variety of different ways and Elsevier has a number of green open access options available. We recommend authors see our green open access page for further information. Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository after an embargo period. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications. Embargo period: For subscription articles, an appropriate amount of time is needed for journals to deliver value to subscribing customers before an article becomes freely available to the public. This is the embargo period and it begins from the date the article is formally published online in its final and fully citable form. Find out more.
This journal has an embargo period of 12 months.
Title page: The title page should include a concise but informative title, which will make the electronic retrieval of the article sensitive and specific; keywords; each author's full name and highest earned academic degree(s); each author's complete affiliation(s), including department(s), institution(s), city, state, and country; and the name and complete mailing address, phone number, fax number and e-mail address of the corresponding author (to whom all correspondence and reprint requests will be directed)
- Confirmation of the fact that the manuscript is not under consideration for publication elsewhere. We encourage disclosure of correspondence from other journals and reviewers, if previously submitted.
- Confirmation that each author fulfills the requirements of Authorship.
- Any potential conflict of interest - if there is no conflict, please state this.
- Confirmation of review committee approval for any experimental studies on human participants and/or confirmation of clinical trial registration.
Keywords:Provide a maximum of 6 keywords (that are not included in the title) on your title page. Please avoid, where possible, general and plural terms and multiple concepts (avoid, for example, 'and', 'of '). Be sparing of abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes.
Body of Text:
- Abstract:The abstract should reflect the content of the article and include the purpose of the study, the experimental design, the most important results and an interpretation of the data, including the conclusion and any implications derived from the results.
- Introduction: State the purpose of the article and summarize the rationale for the study or observation. Give only strictly pertinent references and do not include data or conclusions from the work being reported.
- Materials / Methods:Case studies should contain a concise description of methodology, data and correlative studies.Manuscripts containing the results of experimental studies on human participants must disclose in the first paragraph of the Materials and Methods section whether informed consent was obtained from patients in the study after the nature of the procedure had been fully explained. A statement must be added indicating that an institutional review committee approved the study (with the date of approval).Describe clearly your selection of the observational or experimental subjects (including controls). The guiding principle should be clarity about how and why a study was done in a particular way. For example, authors should explain why only subjects of certain ages were included or why women were excluded. Identify the methods, apparatus and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods; provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dosage(s), and route(s) of administration. Methods should not be included in the Results section or figure legends.
- Results:Present your results in logical sequence in the text, tables and illustrations. Do not repeat in the texts all the data in the tables or illustrations; emphasize or summarize only important observations.
- Discussion/Conclusion:Emphasize the new and important aspects of the study and the conclusions that follow from them. Include the implications of the findings and their limitations, including implications for future research. Relate the observations to other relevant studies. Link the conclusions with the goals of the study, but avoid unqualified statements and conclusions not completely supported by the data. In particular, avoid making statements unless the manuscript contains data to support the claim. Recommendations, when appropriate, may be included.
- Figures, Legends and Tables: should be self-explanatory and should supplement, not duplicate the text. A maximum of 6 illustrations is recommended. Each illustration must be numbered and cited in consecutive order in the text. Place explanatory matter in footnotes, not in the heading. Expand in the footnote all non-standard abbreviations used in each table. For footnotes, identify statistical measures of variations, such as standard deviation and standard error of the mean. A separate list of figure captions must be included in the main body of your paper, following the references. All patient information and institutional identifying data must be removed from illustrations (see Patient Consent section). It is the author's responsibility to obtain written permission for any borrowed, modified or adapted tables or figures from the copyright owner (see Plagiarism section).
Language and Style
The JMIRS is an international journal and it is the aim of the editors to produce papers in clear and concise language. Brief sentences make for easy reading. The text in your manuscript should be easy to read and flow smoothly. A manuscript that is poorly structured, hard to reading and filled with errors is harder to review than one that is well written and where the ideas are presented clearly. Before submitting it for review, please be sure to check your manuscript carefully for structural, spelling and grammatical errors. You may wish to have it reviewed by a third party who has strong English writing and editing skills. Only standard abbreviations and acronyms should be used, and each one should be defined at its first use in the text. Excessive use of abbreviations should be avoided. Be sure that your manuscripts are free of spelling errors. Authors who require information about language editing and copyediting services pre- and post-submission should visit http://www.elsevier.com/languagepolishing for more information.
The description of statistical procedures should be included in the section of Methods and Materials. Statistical methods should be clearly identified and described in sufficient detail for a knowledgeable reader to reproduce the analysis if they had access to the raw data. The choice of method should be motivated. When relevant, the statistical software used and its version number should be stated. The term 'significant' should be reserved for findings that are statistically significant at the 5% level. It should be stated whether P-values are from one- or twosided tests. The JMIRS encourages the reporting of 95% confidence intervals rather than simple P-values whenever relevant. A special concern is the statistical power of analyses showing that a parameter is not significantly associated with the outcome, despite previous reports of a significant association. Here, a confidence interval should be estimated for the effect of this parameter as an indication of the statistical strength of the reported non-significance. Multivariate analyses should be reported with a clear indication of the criteria for selection of parameters to be tested in the model, and how these parameters were represented ('scored') in the model. This applies both for parameters significantly associated with the outcome parameter and parameters for which this is not so.
This journal encourages authors to submit a Data Profile with their article. The Data Profile is a structured summary of the data that have been used for the research described in the article, including brief descriptions and hyperlinks to data sets where applicable. It is displayed with the online (HTML) article on ScienceDirect to allow readers easy access to underlying data sets. With the Data Profile, Elsevier supports authors to make their publications more transparent, reproducible, and of greater utility for their readers. For more information, please visit http://www.elsevier.com/dataprofile.
List funding sources in this standard way to facilitate compliance to funder's requirements:
Funding: This work was supported by the National Institutes of Health [grant numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the United States Institutes of Peace [grant number aaaa].It is not necessary to include detailed descriptions on the program or type of grants and awards. When funding is from a block grant or other resources available to a university, college, or other research institution, submit the name of the institute or organization that provided the funding.
If no funding has been provided for the research, please include the following sentence:This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Color: f, together with your accepted article, you submit usable colour figures then Elsevier will ensure, at no additional charge,that these figures will appear in colour on the web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in colour in the printed version. Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. For colour reproduction in print, you will receive information regarding the total costs from Elsevier after receipt of your accepted article. For further information on the preparation of electronic artwork, please see http://www.elsevier.com/artworkinstructions. Please note: Because of technical complications that can arise from the conversion of colour figures to 'grey scale' (for the printed version should you not opt for colour in print) please submit in addition usable black and white prints corresponding to all the colour illustrations.
Acknowledgement of previously published material should be given in the legend, and the source should be included in the References section. It is the author's responsibility to obtain written permission for any borrowed, modified or adapted text, tables or figures from the copyright owner (usually the original publisher). If text material totaling 250 to 300 words, or any tables, are borrowed verbatim from published sources, written permission is required from both publisher and author. With shorter quotations, it is sufficient to add a bibliographic credit. Permission letters for reproduced text or illustration must accompany the manuscript. If you have been unable to obtain permission, please point this out.
- Elsevier has preprinted forms for use by authors: http://www.elsevier.com/permissions.
- You can also contact Elsevier's Rights Department: firstname.lastname@example.org.
This journal encourages you to cite underlying or relevant datasets in your manuscript by citing them in your text and including a data reference in your Reference List. Data references should include the following elements: author name(s), dataset title, data repository, version (where available), year, and global persistent identifier. Add [dataset] immediately before the reference so we can properly identify it as a data reference. The [dataset] identifier will not appear in your published article.
Most Elsevier journals have their reference template available in many of the most popular reference management software products. These include all products that support Citation Style Language styles, such as Mendeley and Zotero, as well as EndNote. Using the word processor plug-ins from these products, authors only need to select the appropriate journal template when preparing their article, after which citations and bibliographies will be automatically formatted in the journal's style. If no template is yet available for this journal, please follow the format of the sample references and citations as shown in this Guide.
Users of Mendeley Desktop can easily install the reference style for this journal by clicking the following link:
When preparing your manuscript, you will then be able to select this style using the Mendeley plug-ins for Microsoft Word or LibreOffice.
The journal encourages authors to create an AudioSlides presentation with their published article. AudioSlides are brief, webinar-style presentations that are shown next to the online article on ScienceDirect. This gives authors the opportunity to summarize their research in their own words and to help readers understand what the paper is about. More information and examples are available. Authors of this journal will automatically receive an invitation e-mail to create an AudioSlides presentation after acceptance of their paper.
You can enrich your online article by providing 3D radiological data in DICOM format. Radiological data will be visualized for readers using the interactive viewer embedded within your article, and will enable them to: browse through available radiological datasets; explore radiological data as 2D series, 2D orthogonal MPR, 3D volume rendering and 3D MIP; zoom, rotate and pan 3D reconstructions; cut through the volume; change opacity and threshold level; and download the data. Multiple datasets can be submitted. Each dataset will have to be zipped and uploaded to the online submission system via the '3D radiological data' submission category. The recommended size of a single uncompressed dataset is 200 MB or less. Please provide a short informative description for each dataset by filling in the 'Description' field when uploading each ZIP file. Note: all datasets will be available for download from the online article on ScienceDirect. So please ensure that all DICOM files are anonymized prior to submission. More information.
Interactive Case Insights
This journal encourages authors to complement their case reports with test questions that reinforce the key learning points. These author-created questions are submitted along with the article (new or revised) and will be made available in ScienceDirect along with your paper. More information and examples are available at http://www.elsevier.com/about/content-innovation/interactive-case-insights. Test questions are created online at http://elsevier-apps.sciverse.com/GadgetICRWeb/verification. Create the test questions, save them as a file to your desktop, and submit along with your (new or revised) manuscript through EES. For questions, please contact email@example.com.
A signed copyright form should be enclosed with all materials (available here). We cannot publish your article without this signed agreement. Please note that:
- The copyright form stipulates that the material submitted to JMIRS is original and has not been submitted to another publication for concurrent consideration.
- If one has a concern or is in question concerning prior publication, please submit the title page and abstract with submission of materials.
- Acceptance of the agreement will ensure the widest possible dissemination of information.
- For details on copyright policy, please refer to Copyright Information at http://www.elsevier.com/authors.
- As an author, you (or your employer or institution) retain certain rights; for details refer to: http://www.elsevier.com/authorsrights.
- If the manuscript is not published in the JMIRS, this agreement will not take effect.
All allegations of misconduct will be referred to the Editor-In-Chief, who will review the circumstances in consultation with the Deputy Editor. All such allegations will be kept confidential; the number of inquiries and those involved will be kept to the minimum necessary to achieve this end. Initial fact-finding will usually include a request to all the involved parties to state their case, and explain the circumstances, in writing. In questions of research misconduct centering on methods or technical issues, the Editor-In-Chief may confidentially consult experts who are blinded to the identity of the individuals, or if the allegation is against an editor, an outside editor expert. The Editor-In-Chief and Deputy Editor will arrive at a conclusion as to whether there is enough evidence to lead a reasonable person to believe there is a possibility of misconduct. Their goal is not to determine if actual misconduct occurred, or the precise details of that misconduct.
Manuscripts must be submitted via the Elsevier Editorial System (EES) website for this journal; go to http://ees.elsevier.com/jmirs/ and select "Submit Paper." The first time you access EES, you will need to register with a valid email address (all communication will be through this email). You will be guided stepwise through the creation and uploading of your data into a PDF proof, which is then used for peer reviewing. Once your manuscript has been submitted, you can track its progress through the review process. Please note: the Elsevier website offers a tutorial section for authors, as well as 24-hour phone or email assistance should you have any difficulty navigating the system. You can also contact the Managing Editor at firstname.lastname@example.org.
Corresponding authors will receive an e-mail with a link to our online proofing system, allowing annotation and correction of proofs online. The environment is similar to MS Word: in addition to editing text, you can also comment on figures/tables and answer questions from the Copy Editor. Web-based proofing provides a faster and less error-prone process by allowing you to directly type your corrections, eliminating the potential introduction of errors.
If preferred, you can still choose to annotate and upload your edits on the PDF version. All instructions for proofing will be given in the e-mail we send to authors, including alternative methods to the online version and PDF.
We will do everything possible to get your article published quickly and accurately. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. It is important to ensure that all corrections are sent back to us in one communication. Please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Offprints
The corresponding author will, at no cost, receive a customized Share Link providing 50 days free access to the final published version of the article on ScienceDirect. The Share Link can be used for sharing the article via any communication channel, including email and social media. For an extra charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. Both corresponding and co-authors may order offprints at any time via Elsevier's Webshop. Corresponding authors who have published their article open access do not receive a Share Link as their final published version of the article is available open access on ScienceDirect and can be shared through the article DOI link.